Filter Results:
(8,306)
Show Results For
- All HBS Web
(8,306)
- People (23)
- News (1,791)
- Research (5,067)
- Events (38)
- Multimedia (116)
- Faculty Publications (3,990)
Show Results For
- All HBS Web
(8,306)
- People (23)
- News (1,791)
- Research (5,067)
- Events (38)
- Multimedia (116)
- Faculty Publications (3,990)
- 03 Apr 2019
- News
Are MBA Founders More Diverse?
- 24 Apr 2014
- News
Investing in new technologies to accelerate change
Girish Nadkami (MBA 1988), a venture capitalist in Switzerland, talks about the impact of investing in new technologies for communications, robotics, and environmental start-ups. (Published April 2014) View Details
Alexander Civetta
his technology law expertise, and he has also earned distinction as a Superlawyers Rising Star and a Boston Magazine Top Lawyer. He is a Lawyer in Residence at Harvard Business School and has taught venture capital law at Boston... View Details
- Web
Timothy C. Draper | Baker Library
he cofounded Draper and Associates, later renamed Draper Fisher Jurvetson (DFJ). DFJ maintains a loosely affiliated network of semi-independent venture capital firms in the United States, Europe, Asia, and Latin America. The firm has... View Details
- Web
Isabella Mandis | MBA
SaaS, and data science. Formative experience at the intersection of technology and business: Motivated to foster diversity in the venture capital industry, I founded Girls Into VC—the first organization dedicated to empowering the next... View Details
- Profile
Tyler Todd
Why was earning your MBA at HBS important to you? I love my engineering background, but my long-term goals of senior management and running my own company necessitated that I learn how to make sound business decisions. While you can learn finance or accounting basics... View Details
- Profile
Patrick Connolly
Why was earning your MBA at HBS important to you? In my life before business school, I was a concert pianist and music theorist-disciplines that require truly deep, vertical expertise. My decision to attend HBS was consciously designed to broaden my intellectual... View Details
- Profile
Alex Slusky
started the program.” The best simulation of business experience Alex pursued the MBA because he had an interest in venture capital and wanted “to find a way to combine technology and strategy – how do we go up a level in business? Where... View Details
- 21 Jul 2023
- Blog Post
Malcolm McClain (MBA/MPP 2023) Named First RISE Career Fellow
to become better employers. “Throughout my career, I have explored how private capital and public resources can be leveraged to ensure people living in historically marginalized communities have the opportunity for economic mobility,”... View Details
- Web
Entrepreneurial Finance (Q3) - Course Catalog
founder, early employee, advisor or investor. However, the course is also appropriate for students interested in gaining a broader view of the financing landscape for young firms, going beyond the basics of venture capital and angel... View Details
- 01 Oct 2018
- News
Advancing Opportunities for Others
was actually spent in capital markets. I love, love, love my capital markets job. And I'd go back to capital markets in a heartbeat. However, in around 2006, I kept hearing... View Details
Keywords: Finance
- 2004
- Chapter
The Harrod-Domar Model
By: Diego Comin
Comin, Diego. "The Harrod-Domar Model." In An Eponymous Dictionary of Economics, edited by C. R. Braun and Julio Segura. Edward Elgar Publishing, 2004.
- 30 May 2021
- News
How Venture Capitalist David Motley is Trying to Bring Back Pittsburgh’s Black Residents
David Motley (MBA 1988) David Motley (MBA 1988) A recent Wall Street Journal profile details the efforts of venture capitalist David Motley (MBA 1988) to rebuild Pittsburgh’s Black population. As the article notes, the city “has lost 9% of its Black population, and it... View Details
- 11 May 2020
- News
Immigration Policies Threaten American Competitiveness
- 25 Aug 2014
- News
Rishad Premji-led Gambles Win Big
- 24 Apr 2014
- News
Supporting the local community that nurtured him
Franklin P. "Pitch" Johnson (MBA 1952) talks about providing support to local organizations in his hometown of Palo Alto, California. (Published April 2014) View Details
- October 1992 (Revised November 1997)
- Case
ImmuLogic Pharmaceutical Corporation (A): March 1991
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems... View Details
Keywords: Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
- September 1992 (Revised August 2010)
- Case
The Carried Interest
By: Henry B. Reiling
Makes the point that general partners and others frequently contract to receive a share of any profits that the venture they manage generates. This practice raises the question of whether the value of this contract right should be taxed when it is received or only when... View Details
Keywords: Venture Capital; Cash Flow; Profit Sharing; Taxation; Contracts; Business or Company Management; Partners and Partnerships
Reiling, Henry B. "The Carried Interest." Harvard Business School Case 293-043, September 1992. (Revised August 2010.)
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)